IncontiLase vs EMsella for Urinary Incontinence

Urinary incontinence affects millions worldwide, with studies indicating that up to 50% of women over 50 experience some form of incontinence. Female stress urinary incontinence (SUI) is a significant public health problem, with estimated prevalence rates of 4–35% of adult women. While traditional treatments have ranged from pelvic floor exercises to invasive surgery, new technologies have developed that have revolutionizing treatment options. Two leading non-surgical solutions – IncontiLase and EMsella – have emerged as promising alternatives for those seeking relief from the pain and embarrassment of urinary incontinence.

IncontiLase for Urinary Incontinence

IncontiLase utilizes Er:YAG laser technology to address stress urinary incontinence through vaginal tissue remodeling. A 2018 study found that 21% of participants treated with this laser achieved complete dryness, compared to less than 4% in the “sham” (not treated with the laser) group.

The treatment works by delivering precise thermal energy to vaginal tissue, stimulating collagen production and tissue tightening. So why consider IncontiLase?

Minimally invasive, non-surgical procedure
No downtime, can return to normal activities immediately
Quick treatment sessions (15-20 minutes)
No anesthesia required
Clinically proven to strengthen pelvic floor muscles
High patient satisfaction rates reported in studies
Results typically last 12-18 months
Low risk of complications compared to surgical options
Stimulates natural collagen production
Can help with both stress and urge incontinence

EMsella for Treatment of Urinary Incontinence

EMsella takes a different approach, using High-Intensity Focused Electromagnetic (HIFEM) technology to strengthen pelvic floor muscles. During a single 28-minute session, the device induces approximately 11,200 supramaximal contractions – equivalent to performing thousands of Kegel exercises.

A 2019 study found that Emsella had excellent results from most study participants. After the sixth session, 61 out of 75 patients (81.33%) reported significant reduction of their symptoms.

So, why consider EmSella for treating incontinence?

Non-invasive, fully clothed treatment
Delivers thousands of supramaximal pelvic floor contractions per session
30-minute treatment sessions
No downtime
FDA-cleared for treating incontinence
Clinically proven to improve quality of life scores
Can help with both urinary incontinence and intimate wellness
Strengthens deep pelvic floor muscles beyond voluntary capability
Suitable for both men and women
Typically requires 6 sessions over 3 weeks for optimal results

Comparing IncontiLase and EMSELLA

IncontiLase:

2-3 treatments spaced 4-6 weeks apart
Each session takes approximately 30 minutes
Requires 24-48 hours of avoiding strenuous activity
Annual maintenance treatment recommended

EMSELLA:

6 sessions over 3 weeks
28-minute treatments
No downtime
Maintenance every 6-12 months as needed

Patient Selection and Effectiveness

Research indicates that patient selection significantly impacts treatment success. IncontiLase shows optimal results for:

Mild to moderate stress urinary incontinence
Patients with tissue laxity
Women who have completed childbearing

EMsella demonstrates effectiveness for:

Both stress and urge incontinence
Male and female patients
Various age groups and severity levels

Cost Considerations and Accessibility

While costs vary by region and provider, typical treatment courses range:

IncontiLase: $2,500-3,500 for complete treatment series
EMsella: $2,000-3,000 for six sessions

Insurance coverage remains limited for both treatments, though some providers offer payment plans.